Neal M. Lonky
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Neal M. Lonky has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Bradley J. Monk
2 shared publications- Juan Carlos Felix
Departments of Pathology and Obstetrics and Gynecology, University of Southern California, Keck School of Medicine, Los Angeles, CA 90033, USA
2 shared publications - C. Jay Marshall
Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah
1 shared publication Gary Edwards
1 shared publicationGirma Wolde-Tsadik
1 shared publication- Joel S. Bentz
Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah
1 shared publication
Latest Publications
- 1 October 2014
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 18 (4) , 322-325
Do Colposcopically Directed Biopsy and Endocervical Curettage Serve to Induce Regression of Cervical Intraepithelial Neoplasia?
Objective We investigated the clinical and demographic characteristics that could influence regression of cervical intraepithelial neoplasia (CIN) from colposcopy to excision, and evaluated the association of the performance of multiple biopsies and endocervical curettage (ECC) with regression of high-grade (CIN2+) by the time of excisional therapy. Materials and Methods This was an institutional review board–approved retrospective analysis of 555 patients who had abnormal screening and who underwent colposcopy followed by cervical excision procedures for CIN2+ or high-risk status. We assessed demographic variables, referral reason, colposcopic findings, and the latency between colposcopic biopsy and excision to which we correlated the likelihood of regression of disease on the excisional specimen. Results Mean age was 39 years, and median interval from colposcopy to excision was 48 days. Neither demographics nor colposcopic findings influenced the probability of regression. Patients with shorter intervals between colposcopy biopsy and excision exhibited a higher rate of regression (p = .04). The addition of ECC to colposcopy was associated with regression (p = .002). Conclusions During routine colposcopic practice using punch biopsy and ECC when indicated, regression was less likely with longer latency from colposcopy to excision. This was possibly owing to emergence and documentation of persistent occult neoplasia. The effect of intentional complete biopsy excision with conventional tools as a potential therapeutic intervention was not evaluated.
- 1 October 2014
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 18 (4) , 322-325
Do Colposcopically Directed Biopsy and Endocervical Curettage Serve to Induce Regression of Cervical Intraepithelial Neoplasia?
Objective We investigated the clinical and demographic characteristics that could influence regression of cervical intraepithelial neoplasia (CIN) from colposcopy to excision, and evaluated the association of the performance of multiple biopsies and endocervical curettage (ECC) with regression of high-grade (CIN2+) by the time of excisional therapy. Materials and Methods This was an institutional review board–approved retrospective analysis of 555 patients who had abnormal screening and who underwent colposcopy followed by cervical excision procedures for CIN2+ or high-risk status. We assessed demographic variables, referral reason, colposcopic findings, and the latency between colposcopic biopsy and excision to which we correlated the likelihood of regression of disease on the excisional specimen. Results Mean age was 39 years, and median interval from colposcopy to excision was 48 days. Neither demographics nor colposcopic findings influenced the probability of regression. Patients with shorter intervals between colposcopy biopsy and excision exhibited a higher rate of regression (p = .04). The addition of ECC to colposcopy was associated with regression (p = .002). Conclusions During routine colposcopic practice using punch biopsy and ECC when indicated, regression was less likely with longer latency from colposcopy to excision. This was possibly owing to emergence and documentation of persistent occult neoplasia. The effect of intentional complete biopsy excision with conventional tools as a potential therapeutic intervention was not evaluated.
- 1 October 2007
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 11 (4) , 258-264
Cost-Effectiveness of Adding Human Papilloma Virus Testing to a Managed Care Cervical Cancer Screening Program
The purpose of this study was to demonstrate a methodology for auditing the impact of HCII testing on the direct cost of cervical cancer cytological screening, where the test is collected in all women screened and processed routinely in women age 30 years and older. After a policy change to screen all patients 30 years or older with both Pap smears and high-risk human papillomavirus (HR-HPV), as well as cocollection of HR-HPV in women younger than 30 years, all cytological, HPV, and histological data pertaining to cervical screening was collected retrospectively during a 2-month period. We documented the direct costs of performing these tests and estimated the necessary compliance rate for balanced cost-effectiveness. During the 2-month period, 8,300 women were screened with both Pap smear and HPV cocollection. Of the 'nonnormal' cytological findings, 5% of patients showed either atypical squamous cells (3.5%) or squamous intraepithelial abnormalities (1.5%). An additional 427 (5%) patients had the finding of positive HR-HPV with normal cytology. Six of these patients opted for immediate colposcopy, 2 of which were found to have cervical intraepithelial neoplasia 2. In women age 30 years and older, 900 patients per 1,000 screened would be eligible for a 2-year screening interval based on negative cytology and negative HR-HPV. Based on the direct costs associated with this cohort, no more than 164 women could request screening at an interval shorter than 3 years for the total costs of such a program to equal that of one without HR-HPV cocollection. By adding HCII collection to the Pap smear for our entire screening cohort, we intended to reduce the number of tests performed, which was impacted by its age distribution. Our findings indicate that at least 736 of the 900 double-negative patients (82%) would have to be screened at no less than 3 years for such a screening paradigm to be cost-effective in managing women 30 years and older.
- 1 October 2007
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 11 (4) , 258-264
Cost-Effectiveness of Adding Human Papilloma Virus Testing to a Managed Care Cervical Cancer Screening Program
The purpose of this study was to demonstrate a methodology for auditing the impact of HCII testing on the direct cost of cervical cancer cytological screening, where the test is collected in all women screened and processed routinely in women age 30 years and older. After a policy change to screen all patients 30 years or older with both Pap smears and high-risk human papillomavirus (HR-HPV), as well as cocollection of HR-HPV in women younger than 30 years, all cytological, HPV, and histological data pertaining to cervical screening was collected retrospectively during a 2-month period. We documented the direct costs of performing these tests and estimated the necessary compliance rate for balanced cost-effectiveness. During the 2-month period, 8,300 women were screened with both Pap smear and HPV cocollection. Of the 'nonnormal' cytological findings, 5% of patients showed either atypical squamous cells (3.5%) or squamous intraepithelial abnormalities (1.5%). An additional 427 (5%) patients had the finding of positive HR-HPV with normal cytology. Six of these patients opted for immediate colposcopy, 2 of which were found to have cervical intraepithelial neoplasia 2. In women age 30 years and older, 900 patients per 1,000 screened would be eligible for a 2-year screening interval based on negative cytology and negative HR-HPV. Based on the direct costs associated with this cohort, no more than 164 women could request screening at an interval shorter than 3 years for the total costs of such a program to equal that of one without HR-HPV cocollection. By adding HCII collection to the Pap smear for our entire screening cohort, we intended to reduce the number of tests performed, which was impacted by its age distribution. Our findings indicate that at least 736 of the 900 double-negative patients (82%) would have to be screened at no less than 3 years for such a screening paradigm to be cost-effective in managing women 30 years and older.
- 1 March 2003
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 101 (3) , 481-489
Triage of Atypical Squamous Cells of Undetermined Significance With Hybrid Capture II
- 1 March 2003
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 101 (3) , 481-489
Triage of Atypical Squamous Cells of Undetermined Significance With Hybrid Capture II
- 1 December 2002
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 100 (6) , 1276-1284
A Stiff Bristled, Spiral-Shaped Ectocervical Brush
OBJECTIVE To compare a new spiral-shaped tissue-sampling brush with a standard cervical punch biopsy. METHODS Before large loop excision of the transformation zone, women with cervical intraepithelial neoplasia underwent a transepithelial brush biopsy of a portion of a colposcopically identified lesion, followed by a punch biopsy of the remaining portion. Brush biopsy samples were processed using liquid-based cytology and cell block techniques. Diagnoses were made using a consensus of three pathologists. Brush biopsy samples without basal cells were considered inadequate. The histological diagnosis was compared with the brush biopsy and punch biopsy samples. Patient-reported pain and physician-reported bleeding for punch and brush biopsies were compared. RESULTS Fifty-two women were enrolled in the study; 47 successfully completed the study protocol. Eight brush biopsy specimens were inadequate. Thirty-nine women showed abnormal pathology (human papillomavirus/cervical intraepithelial neoplasia I or worse) on large loop excision of the transformation zone, and 32 women had high-grade (or worse) lesions. The punch biopsy correlated with high-grade disease in 53.1% of these women. The brush biopsy result correlated with high-grade disease in 79.3% of these women using a cell block technique and 76.7% using liquid cytology. There was significantly less pain (P < .001) and significantly less bleeding (P < .001) with the brush biopsy. CONCLUSION When an adequate sample is collected, spiral brush biopsy is as good as a standard punch biopsy for detecting cervical pathology, with substantially less pain and bleeding. User training and guidelines for sampling are needed to assure that an adequate sample is collected.
- 1 December 2002
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 100 (6) , 1276-1284
A Stiff Bristled, Spiral-Shaped Ectocervical Brush
OBJECTIVE To compare a new spiral-shaped tissue-sampling brush with a standard cervical punch biopsy. METHODS Before large loop excision of the transformation zone, women with cervical intraepithelial neoplasia underwent a transepithelial brush biopsy of a portion of a colposcopically identified lesion, followed by a punch biopsy of the remaining portion. Brush biopsy samples were processed using liquid-based cytology and cell block techniques. Diagnoses were made using a consensus of three pathologists. Brush biopsy samples without basal cells were considered inadequate. The histological diagnosis was compared with the brush biopsy and punch biopsy samples. Patient-reported pain and physician-reported bleeding for punch and brush biopsies were compared. RESULTS Fifty-two women were enrolled in the study; 47 successfully completed the study protocol. Eight brush biopsy specimens were inadequate. Thirty-nine women showed abnormal pathology (human papillomavirus/cervical intraepithelial neoplasia I or worse) on large loop excision of the transformation zone, and 32 women had high-grade (or worse) lesions. The punch biopsy correlated with high-grade disease in 53.1% of these women. The brush biopsy result correlated with high-grade disease in 79.3% of these women using a cell block technique and 76.7% using liquid cytology. There was significantly less pain (P < .001) and significantly less bleeding (P < .001) with the brush biopsy. CONCLUSION When an adequate sample is collected, spiral brush biopsy is as good as a standard punch biopsy for detecting cervical pathology, with substantially less pain and bleeding. User training and guidelines for sampling are needed to assure that an adequate sample is collected.
- 1 December 2002
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 29 (4) , 817-842
Risk factors related to the development and mortality from invasive cervical cancer
- 1 December 2002
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 29 (4) , 817-842
Risk factors related to the development and mortality from invasive cervical cancer